Back
Arrowhead Pharmaceuticals Vs. Sagimet Biosciences Industry Stock Comparison
Sell
16
ARWR
Arrowhead Pharmaceuticals
Last Price:
22.39
Seasonality Move:
2.52%
Sell
49
SGMT
Sagimet Biosciences
Last Price:
4.51
Seasonality Move:
--
Sell
16
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $22.08. The Score for ARWR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sagimet Biosciences (SGMT)
is a Sell
Is Sagimet Biosciences a Buy, Sell or Hold?
- The current Sagimet Biosciences [SGMT] share price is $4.44. The Score for SGMT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SGMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $22.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
SGMT Stock Price Chart
What is Sagimet Biosciences's stock price today?
-
The Sagimet Biosciences share price today is $4.44
The current trend is relatively stagnant and SGMT is experiencing selling pressure, which indicates risk of future bearish movement.
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 37.09 | Sell |
| Chaikin Money Flow: | -2139533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.63 - 25.17) | Sell |
| Bollinger Bands (100): | (25.23 - 33.77) | Sell |
SGMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 48.15 | Sell |
| Chaikin Money Flow: | -211221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.97 - 4.83) | Buy |
| Bollinger Bands (100): | (3.61 - 8.91) | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.25 | Sell |
| 20-day SMA: | 23.49 | Sell |
| 50-day SMA: | 26.65 | Sell |
| 200-day SMA: | 28.47 | Sell |
| 8-day EMA: | 23.93 | Sell |
| 20-day EMA: | 24.19 | Sell |
| 50-day EMA: | 25.97 | Sell |
| 200-day EMA: | 29.05 | Sell |
SGMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.37 | Buy |
| 20-day SMA: | 4.22 | Buy |
| 50-day SMA: | 4.83 | Sell |
| 200-day SMA: | 7.31 | Sell |
| 8-day EMA: | 4.38 | Buy |
| 20-day EMA: | 4.42 | Buy |
| 50-day EMA: | 4.97 | Sell |
| 200-day EMA: | 1.21 | Buy |
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.02 per share, a decrease this year of $1.62 per share, and an increase next year of $0.15 per share.
Sagimet Biosciences Earnings Growth & SGMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.22 per share, and a decrease next year of $1.68 per share.
Arrowhead Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sagimet Biosciences Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||